GLP-1 for Addiction Treatment
Recent medical breakthroughs continue to shape how we approach complex health conditions. In recent years, glucagon-like peptide-1 (GLP-1) has made major headlines for its profound impact on diabetes and weight management. Now, new research is finding that GLP-1 medications might be effective in treating and preventing substance use disorders. But how does GLP-1 for addiction work?
GLP-1 receptor agonists are semaglutide drugs like Ozempic and Wegovy. Tirzepatide drugs like Mounjaro and Zepbound are another class of GLP-1 receptor agonists that have also exploded in use for weight loss and weight management. In addition to weight loss, many patients on these medications have also reported a decreased interest in alcohol and nicotine.
As addiction recovery specialists look for more effective ways to help support patients, GLP-1 medications are revealing unexpected benefits for those who struggle with chemical dependency. Some early studies suggest that GLP-1 may be effective in treating opioid, alcohol and nicotine addictions by reducing cravings by up to 40% over a period of three weeks.
In fact, some doctors are already prescribing GLP-1 medications off-label for the treatment of substance use disorders. Despite these new findings, there is not sufficient clinical evidence that supports choosing this method over evidence-proven addiction treatments such as medical detox, medication-assisted treatment and cognitive behavioral therapy.
The Drug Addiction Crisis
According to data from publications by the United Nations, there are an estimated 35 million people worldwide who suffer from substance use disorders. Drug addiction does not discriminate and impacts everyone no matter the age, race, gender or social and economic background.
Substance use disorders are diagnosed based on criteria that are typically found in four specific categories: physical dependence, risky use, social problems and impaired control.
The negative consequences of drug addiction represent a global issue that impacts families, individuals, communities and societal health overall. This disease impacts more than 48 million Americans. Despite the recent decades-long drug overdose crisis in the U.S, the FDA has approved fewer than 10 medications that can treat substance addiction.
Despite the growing problem of drug abuse and addiction, there is also an underutilization of treatment. This is often due to many factors, including social, personal and environmental barriers, breakdowns on clinical and organizational levels, and general stigma towards the disease.
How does GLP-1 for Addiction work?
Historically, addiction has been viewed through the lens of dopamine, which is the brain’s primary “feel good” neurotransmitter. When a person consumes alcohol or drugs, the brain experiences a massive dopamine spike. With continued use, the brain will require more and more of the substance in order to achieve the same effects. This leads to physical and psychological dependence, which can slowly turn into addiction.
Research on GLP-1 indicates that GLP-1 receptors aren’t just located in the pancreas or gut. They are also expressed in regions of the brain that have been previously identified as important in the neurobiology of addiction and can cross the blood-brain barrier.
Scientists have found that GLP-1 receptors are also connected to parts of the brain responsible for impacting reward and motivation. Those who take GLP-1 for weight management often report a quieting of food noise. If these receptors are activated in the brain area that impacts reward, it is possible that it can also quiet drug noise in the brain.
This means the medication has the possibility of blunting the exaggerated dopamine spikes that cause cravings for addictive substances.
However, much of the research is still being done with animal studies. The role of GLP-1 for alcohol use disorder in animal studies probably has the most extensive research compared to other drugs. Scientists have found that the medication can effectively reduce dopamine release in the brain’s reward centers when the subject is being exposed to addictive substances like drugs and alcohol. This just shows how drug dependence works on a molecular level.
How GLP-1 for Addiction can alter cravings
For patients struggling with alcohol addiction, the mechanisms of GLP-1 show that when they are interacting with the brain’s reward centers, the pull to binge drink significantly diminishes. Scientists and researchers are now monitoring FDA clinical trials for semaglutide and its impact on alcohol use disorder. The trials are to establish more formal dosing guidelines and understand the long-term efficacy of this type of treatment.
Research has also been analyzing how it differs from traditional and approved treatments such as naltrexone. Naltrexone works by blocking opioid receptors that reduce the euphoric feelings alcohol can produce. GLP-1 medications work to reduce cravings before the first drink is taken. The combination of these therapies could be life-changing in preventing alcohol relapse.
When it comes to nicotine, breaking the habit of smoking is one of the hardest addictions to break. Physicians are increasingly noting that off-label use of Ozempic for nicotine withdrawal is a highly beneficial side effect for obese patients who also happen to smoke. GLP-1 medication reduces the reward associated with a dopamine-triggering event like smoking; patients often find nicotine less satisfying.
Check Your Insurance Coverage for FREE
Find out if your insurance covers addiction treatment in minutes. We accept most insurance!
Integrating GLP-1 for Addiction and Comprehensive Recovery
Incorporating GLP-1 for addiction treatment into a care plan represents a new shift in behavioral health. GLP-1 can help addicts dampen cravings and compulsions manipulated in the reward pathway of the brain by addictive substances. By ensuring the brain’s reward centers are stabilized, patients are significantly less likely to seek out new and potentially harmful dopamine sources to replace the ones they stopped using.
But medication alone is never the cure-all. To maximize the benefits of the drug, they must be integrated into a comprehensive recovery treatment plan that includes behavioral therapies, nutritional counseling and community support.
Cognitive behavioral therapy is necessary to address underlying emotional and psychological triggers of addiction and to understand how it impacts mental health behaviors.
It is also important to support metabolic repair that requires a nutrient-dense diet. Healthy eating can lead to a healthy body, which leads to a healthy brain.
Group counseling, family therapy and support groups like AA and NA are vital in the social support necessary for long-term sobriety.
Reach out to Hotel California by the Sea
We specialize in treating addiction and other co-occurring disorders, such as PTSD. Our Admissions specialists are available to walk you through the best options for treating your addiction.
Treatment for Substance Use Disorder
Despite all of the positive findings in GLP-1 for addiction, it is still too soon to say it can be a solution for substance addiction. As ongoing clinical trials progress, addiction specialists are hopeful that it can continue to produce positive results and transition into FDA-approved treatments.
The journey of addiction recovery is personal and challenging. Professional behavioral programs like Hotel California by the Sea offer a wide range of personalized treatment plans to address substance use disorders. We offer treatment at all levels of care including detox, residential, PHP and IOP. We utilize evidence-based methods such as CBT, DBT and family therapy. Hotel California by the Sea is dedicated to helping clients reach their goals in sobriety and overcome their addiction.
References:
https://med.stanford.edu/news/insights/2025/04/ozempic-addiction-glp-1s-mounjaro-lembke.html
https://pmc.ncbi.nlm.nih.gov/articles/PMC8820218
https://www.science.org/content/article/obesity-drugs-linked-lower-addiction-rates-large-study-veterans
https://medicine.washu.edu/news/glp-1-medications-get-at-the-heart-of-addiction-study
https://drugfree.org/article/can-glp-1-medications-like-ozempic-help-in-addiction-treatment/
